Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100349905C discloses novel Tropp ligands enabling high-efficiency asymmetric hydrogenation. Discover supply chain advantages and technical feasibility.
Advanced patent-based felodipine synthesis ensures high purity and cost efficiency for global pharmaceutical supply chains and manufacturing partners.
Patent CN109970659B reveals a green nickel-catalyzed route for benzimidazole and quinazoline intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN105524100B analysis reveals safer vinyl potassium trifluoborate production. Eliminating ultra-low temperatures reduces costs and enhances supply chain reliability for global pharmaceutical manufacturers significantly.
Patent CN106565439B reveals a one-step oxidation method achieving 99.7% purity. This process significantly reduces wastewater and enhances supply chain reliability for global buyers.
Novel one-pot Grignard method for alkyl phenylboronic acid reduces cost and time. Ideal for high-purity pharmaceutical and agrochemical intermediate manufacturing.
Patent CN113999166B details a novel Negishi coupling route for Tenibulin, offering milder conditions and higher yields for cost-effective API manufacturing.
Patent CN110938107B reveals a low-temp alkylation route for fulvestrant intermediates, offering high purity and cost reduction in pharmaceutical manufacturing.
Patent CN104447506B details a high-yield synthesis route for 2-acetyl-9-alkyl carbazoles offering significant supply chain and cost advantages for pharmaceutical intermediates manufacturing.
Novel scalable synthesis of 1-phenyl vinyl borate via Pd-catalyzed borylation. Cost-effective reagents and simplified purification for reliable supply chain.
Patent CN113292589B reveals a mild SmI2-catalyzed THF ring-opening method. Achieve high yields and cost reduction in fine chemical manufacturing with scalable silane synthesis.
Patent CN104328152A details high-yield biocatalytic synthesis offering supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Patent CN108586350A reveals metal-free tandem cyclization for high-purity imidazole-2-thiones. Offers substantial cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN112645854B details a novel purification method for Apremilast intermediates using PEG-modified catalysts and specific solvent systems to achieve over 99.5% purity.
Patent CN103420870A details a novel carbonylation route for high-purity chiral 4-cyano-3-hydroxybutyrate, offering significant cost reduction and scalable manufacturing for statin intermediates.
Advanced manufacturing of L-Phenylephrine HCl using optimized Rh-catalysis for high purity and cost-effective supply chain solutions.
Novel preparation method for Canagliflozin intermediates ensures high purity and yield. Ideal for reliable pharmaceutical intermediate suppliers seeking cost-effective scale-up.
Patent CN106831522A reveals Pd-catalyzed C-H activation for lactam synthesis. Enables cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN108840821A reveals a novel cobalt complex synthesis offering high conversion rates and simplified processes for pharmaceutical intermediate production.
Patent CN1409702A details a cost-effective asymmetric synthesis of Casodex enantiomers using citramalic acid, offering supply chain advantages over proline-based methods.